Worldwide Clinical Trials: Director, Marketing Strategy – Oncology and Neuroscience – Europe – Homebased
Orexo Submits New Drug Application to FDA for OX124, a High-Dose Rescue Medication for Opioid Overdose
Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
Apellis Announces U.S. FDA Approval of the Empaveli Injector, a Device to Streamline Self-Administration